(NYSE: DGX) Quest Diagnostics's forecast annual revenue growth rate of 4.53% is not forecast to beat the US Diagnostics & Research industry's average forecast revenue growth rate of 5.11%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 9.68%.
Quest Diagnostics's revenue in 2025 is $10,158,000,000.On average, 9 Wall Street analysts forecast DGX's revenue for 2025 to be $1,203,942,794,976, with the lowest DGX revenue forecast at $1,201,867,491,552, and the highest DGX revenue forecast at $1,207,730,921,448. On average, 9 Wall Street analysts forecast DGX's revenue for 2026 to be $1,248,950,310,045, with the lowest DGX revenue forecast at $1,239,577,953,994, and the highest DGX revenue forecast at $1,261,279,666,479.
In 2027, DGX is forecast to generate $1,295,545,616,432 in revenue, with the lowest revenue forecast at $1,291,220,523,341 and the highest revenue forecast at $1,300,106,706,912.